RCB18350
RCB18350 is an antituberculosis agent that belongs to the class of isoxazole derivatives. RCB18350 has bacteriostatic activity and inhibits the growth of Mycobacterium tuberculosis with an MIC of 1.25 μg/mL. RCB18350 is effective against multidrug-resistant Mycobacterium tuberculosis (MDR-TB) clinical isolates, slow-growing mycobacteria such as Mycobacterium bovis BCG and Mycobacterium avium[1].
Product Specifications
CAS Number
3052630-27-7
UNSPSC
12352005
Target
Bacterial
Related Pathways
Anti-infection
Field of Research
Infection
Smiles
CCOC(C1=NOC(CCCSC2=CC=C(C3=NOC(C(F)(F)F)=N3)C=C2C)=C1)=O
Molecular Formula
C19H18F3N3O4S
Molecular Weight
441.42
References & Citations
[1]Recchia D, et al. Mycobacterium tuberculosis Sulfate Ester Dioxygenase Rv3406 Is Able to Inactivate the RCB18350 Compound. ACS Infect Dis. 2025 Apr 11;11 (4) :986-997.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
